Rigel Pharmaceuticals (RIGL) Shares Outstanding (2010 - 2026)

Rigel Pharmaceuticals' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $18.5 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 3.52% year-over-year to $18.5 million in Q1 2026; TTM through Mar 2026 was $18.5 million, a 3.52% increase from a year earlier, with the FY2025 full-year figure at $18.3 million, up 3.39% from the prior year.
• Shares Outstanding (Entity) improved to $18.5 million in Q1 2026 per RIGL's latest filing, from $18.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $18.5 million in Q1 2026 and bottomed at $17.2 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $17.5 million (2024), against an average of $17.7 million.
• Across the five-year window, Shares Outstanding (Entity) rose 0.82% in 2023 and increased 3.52% in 2026, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $17.3 million in 2022, then advanced by 0.82% to $17.5 million in 2023, then advanced by 1.3% to $17.7 million in 2024, then climbed by 3.39% to $18.3 million in 2025, then rose by 1.04% to $18.5 million in 2026.
• Per Business Quant, the three latest RIGL Shares Outstanding (Entity) figures stand at $18.5 million (Q1 2026), $18.3 million (Q4 2025), and $18.2 million (Q3 2025).